CClinicalTrials.gg
CompletedNCT07062159Updated Jan 7, 2026

Psychoeducational Intervention to Reduce Depressive Symptoms and Strengthen Mother-Infant Bonding

An interventional study of the psychoeducation intervention program and routine care in Postpartum Depression, Psychoeducation and Mother-Infant Interaction, sponsored by Yasemin Ozhuner. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-07.

Sponsored by Yasemin Ozhuner · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
88
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The study aims to evaluate the effectiveness of a psychoeducational intervention designed within the framework of the Watson Human Caring Model in reducing postpartum depressive symptoms and creating a stronger mother-infant bond. Specifically, it aims to investigate whether a person-centered approach based on the principles of Watson's caring science can significantly increase the psychological well-being of postpartum mothers and improve the quality of their relationship with their babies.

Read the detailed description

The pregnant women included in the sample were informed about the study and their written consent was obtained. Six interviews were conducted with the pregnant women, four at one-week intervals before birth and one on the seventh day and fourth week after birth. These interviews were conducted with the women one-on-one and face-to-face. The women in the control group did not receive any treatment other than routine care at family health centers. The psychoeducation program was applied to the women in the intervention group in six interviews.

02

Conditions studied

  • Postpartum Depression
  • Psychoeducation
  • Mother-Infant Interaction

Keywords

  • Postpartum Depression
  • Watson model
  • psychoeducation
  • Mother-Infant Interaction
03

In context

Depression, Postpartum

528 studies on the registry are indexed under Depression, Postpartum; 124 are open to participants now.

This study's enrollment of 88 is below the median of 105 across 425 interventional studies indexed under Depression, Postpartum.

Browse Depression, Postpartum studies →

Lead sponsor

Yasemin Ozhuner is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

    • Women in their 20-35th week of pregnancy,

      • Volunteers,
      • Over 18 years of age,
      • Literate,
      • No visual, hearing or mental disabilities,
      • Having a healthy baby weighing over 2500 grams,
      • Being in the same environment with their baby after birth,
      • Having a healthy fetus on ultrasound will be included in the study.

Exclusion criteria

Exclusion Criteria:

    • Those diagnosed with depression or other mental illnesses by a physician,

      • Those taking medication for mental illness,
      • Women who have given birth prematurely,
      • Stillbirth,
      • Those who have not participated in more than one interview will not be included in the study.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
88 participants (actual)

Study arms

  • Active comparator
    intervention group

    Active Comparator: intervention group The pregnant women in the sample were informed about the study and their written consent was obtained. A total of six interviews were conducted with the pregnant women, four at one-week intervals before birth and one interview on the seventh day and fourth week after birth. These interviews were conducted with the women one-on-one and face-to-face. The psychoeducation program was applied to the women in the intervention group in six interviews. In the first interview, the women were given a booklet of the psychoeducation intervention program based on the Watson Human Caring Model for postpartum care and the interview was conducted within the scope of the program. The psychoeducation intervention program interviews based on the Watson Human Caring Model in the study were conducted according to the Watson Human Caring Model improvement processes and psychoeducation techniques. The interviews lasted between 60-90 minutes on average.

    Other: the psychoeducation intervention program

  • Placebo comparator
    control group

    Placebo Comparator: Control Group The pregnant women in the sample were informed about the study and their written consent was obtained. Six interviews were conducted with the pregnant women, four at one-week intervals before delivery and once on the seventh day and fourth week after delivery. These interviews were conducted with the women one-on-one and face-to-face. The women in the control group did not receive any treatment other than their routine care at family health centers. In routine care, pregnant women were examined for edema, varicose veins, weight, blood pressure, pulse, laboratory findings, baby heart sounds, medication intake, chronic disease follow-up and vaccination. Pregnant women were provided with counseling if they had any questions. After delivery, women were provided with medication intake, blood pressure, fever, pulse, bleeding and laboratory findings and counseling if they had any questions.

    Other: routine care

Interventions

  • Otherthe psychoeducation intervention program

    The content of the psychoeducation intervention program based on the Watson Human Caring Model will consist of the postpartum process and care, maternal blues, postpartum psychosis, postpartum depression, frequency, causes, predisposing factors, symptoms, effects on mother, child and community health, diagnosis and treatment, preventive practices, social support, adaptation to the role of motherhood, mother and baby bonding, practices that will strengthen mother-baby bonding, breast milk and breastfeeding, nutrition and baby care, problems encountered in baby care and solution suggestions.

  • Otherroutine care

    routine care

06

What researchers measure

Primary outcomes

  1. Prenatal Attachment Scale

    Prenatal Attachment Scale The scale consists of 21 items in total. The highest score on the scale is 84, the lowest score is 21, and the increase in the total score obtained from the scale indicates that prenatal attachment is positive.

    Time frame: 1 day (first meeting during pregnancy)

  2. Edinburgh Postpartum Depression Scale

    It is a 10-item self-report scale that measures maternal depressive symptoms over the past seven days. Higher scores reflect more depressive symptoms. Symptoms are rated on a 4-point Likert scale with scores ranging from 0 to 30. The cut-off score of the scale was determined as ≥13. If the total score of the scale is 12 or less, the participant is not at risk for PPD, but if he scores 13 or more, he is at risk.

    Time frame: 1 day (first meeting during pregnancy and at the fourth week postpartum)

  3. Mother-Infant Attachment Scale

    Mother-Infant Attachment Scale This scale, which is used from the first day after birth, allows the mother to describe her feelings towards her baby in one word. The lowest score that can be obtained from the scale is 0 and the highest score is 24. As the score increases, attachment is negatively affected.

    Time frame: fourth week postpartum

07

Study locations

1 site
  • Eskisehir Osmangazi University
    Eskişehir, Odunpazarı 26000, Turkey (Türkiye)
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07062159
Lead sponsor
Yasemin Ozhuner
Responsible party
Yasemin Ozhuner (DR, Eskisehir Osmangazi University) — Sponsor-investigator
First posted
Jul 14, 2025
Start date
Jul 2, 2025
Primary completion
Aug 19, 2025
Completion
Jan 5, 2026
Last update
Jan 7, 2026

Study contacts

Yasemin Özhüner
principal investigator · Eskişehir Vadişehir Family center odunpazarı Turkey
Nebahat Ozerdogan
study director · Eskisehir Osmangazi University odunpazarı turkey

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion